Nippon Telegraph & Telephone
9432
Metaplanet
3350
NTT Data Group
9613
4
Toyota Motor
7203
5
Nintendo
7974
JP Stock MarketDetailed Quotes
4563 AnGes
- 66
- -10-13.16%
20min DelayNot Open May 8 15:30 JST
22.01BMarket Cap-0.55P/E (Static)
76High65Low16.70MVolume75Open76Pre Close1.17BTurnover9852wk High5.32%Turnover Ratio333.51MShares4352wk Low-119.53EPS TTM20.71BFloat Cap5596Historical HighLossP/E (Static)313.82MShs Float43Historical Low-119.53EPS LYR14.47%Amplitude--Dividend TTM10.01P/B100Lot Size--Div YieldTTM
About AnGes Company
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Company Profile
Symbol4563
Company NameAnGes
Founded1999-12-17
MarketTSE Growth
Employees55
Fiscal Year Ends12-31
Address7-7-15, Saito-asagi 4F, Saito Bio-Incubator
Zip Code108-0014
Phone---
Websitewww.anges.co.jp
Company Executives
- Name
- Position
- Salary
- Ei Yamada
- Representative Director , President and Chief Executive Officer
- --
- Shoya Satou
- Director
- --
- Norikazu Eiki
- Independent Director
- --
- Makoto Hara
- Independent Director
- --
- Kimiko Murofushi
- Independent Director
- --
- Junichi Komamura
- Independent Director
- --